At Top One Research Group, you benefit from a research partner that connects advanced clinical studies with compassionate care in South Florida. We focus on running high-quality, compliant trials that support patient safety, clear communication, and reliable results. Our goal is to help you access new treatment opportunities while advancing medicine with integrity, innovation, and hope.

Each study has specific eligibility criteria, such as age, medical history, and current health status. If you’re interested in participating, you can contact our team, who will ask a few initial questions to determine if you meet the study’s requirements. This preliminary check helps ensure that the study is a good fit for you.

**Interventional Trials**: These studies involve participants receiving a specific treatment, such as a new drug or therapy, to study its effects on a condition. Researchers actively intervene by administering the treatment and observing its impact on participants' health. For instance, an interventional trial might test whether a new medication can lower blood pressure in patients with hypertension. **Prospective Collections**: Unlike interventional trials, these studies do not involve administering new treatments. Instead, researchers collect health information, samples, or other data over time to observe how conditions develop naturally or how health changes in specific populations. This approach helps identify patterns and gather data for future studies without altering participants' treatments or routines.

An Institutional Review Board (IRB) is an independent committee that reviews clinical trial protocols to ensure they are ethical and prioritize participant safety. Before a study begins, the IRB evaluates the study design, potential risks, and safeguards for participants. IRB approval is mandatory for any study to proceed, ensuring the highest standards of safety and ethics.

Once a clinical trial concludes, researchers analyze the collected data to assess the effectiveness and safety of the treatment or intervention. Results are shared with regulatory bodies, which may lead to new treatment approvals. Participants are often given the option to receive follow-up information on the study's results or continue in an extension study if applicable.